These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11243204)

  • 1. [Preliminary study on the absorption, distribution and excretion of doxophylline in rats].
    Guo H; Xu XY; He LY; Huang JH
    Yao Xue Xue Bao; 1997; 32(2):81-4. PubMed ID: 11243204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic profile of naftopidil in rats].
    Yu D; Wan L; Lou Y
    Yao Xue Xue Bao; 1998 May; 33(5):335-8. PubMed ID: 12016999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and metabolic studies of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine in the rat.
    Cravanzola C; Grosa G; Franzone JS
    Drugs Exp Clin Res; 1990; 16(6):285-91. PubMed ID: 2086163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of zinc acexamate (ZAC) in rats].
    Li HY; Liu XM; Ji XJ
    Yao Xue Xue Bao; 1995; 30(1):17-20. PubMed ID: 7660785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
    Zhong DF; Li K; Xu JH; Du Y; Zhang YF
    Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, tissue distribution, excretion, and metabolism of clothianidin in rats.
    Yokota T; Mikata K; Nagasaki H; Ohta K
    J Agric Food Chem; 2003 Nov; 51(24):7066-72. PubMed ID: 14611173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of doxophylline by rat liver microsomes.
    Grosa G; Franzone JS; Biglino G
    Drug Metab Dispos; 1986; 14(2):267-70. PubMed ID: 2870905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary pharmacokinetics of the new antitussive compound vadocaine hydrochloride in animals.
    Mäntylä R; Männistö PT; Vuorela A; Nissinen E
    Arzneimittelforschung; 1988 Apr; 38(4A):624-7. PubMed ID: 3395399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of epristeride in rats and beagle dogs].
    Wei GL; Xiao SH; Liu CX
    Yao Xue Xue Bao; 2000 Oct; 35(10):721-4. PubMed ID: 11372434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine by rat liver microsomes. Diastereoselective metabolism of the 1,3-dithiolane ring.
    Grosa G; Caputo O; Ceruti M; Biglino G; Franzone JS; Cravanzola C
    Drug Metab Dispos; 1991; 19(2):454-7. PubMed ID: 1676653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The physiologic disposition and pharmacokinetics of guaiacol acetylsalicylate in rats].
    Qu SY; Li W; Chen YL; Sun Y; Zhang YQ; Hong T
    Yao Xue Xue Bao; 1990; 25(9):664-9. PubMed ID: 2092574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
    He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
    Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of protein-calorie malnutrition on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
    Bae SK; Lee SJ; Kwon JW; Kim WB; Lee MG
    J Pharm Pharmacol; 2004 May; 56(5):635-42. PubMed ID: 15142341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo.
    Ono C; Yamada M; Tanaka M
    J Pharm Pharmacol; 2003 Dec; 55(12):1647-54. PubMed ID: 14738591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
    Beránková K; Szkutová M; Balíková M
    Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, distribution, metabolism and excretion of YM466, a novel factor Xa inhibitor, in rats.
    Mano Y; Sonoda T; Nakamura E; Usui T; Kamimura H
    Biopharm Drug Dispos; 2004 Sep; 25(6):253-60. PubMed ID: 15334624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.